The classic MEN2A susceptibility mutation in codon 634 is estimated at 3.7 live births per million, with 97% of patients presenting with MTC, half with pheochromocytoma, and one-fifth with primary hyperparathyroidism (3). This evidence concerns the gene RET and hereditary pheochromocytoma-paraganglioma.